ASTEC INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ASTEC INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,147	1,185	1,172	1,170	1,024	1,096	1,275	1,338	1,305	1,410
Cost of revenue	882	942	1,036	930	787	846	1,010	1,007	977	1,036
Gross profit	265	243	136	239	238	250	264	331	328	374
Research and development	25	26.8	28.3	27.2	22.1	26.5	31.5	22	23.8	26.9
Selling, general and administrative		161	181	184	167	227	248	276	276	309
Selling and marketing							60.2	72.2	72.4	78.7
General and administrative							67.5	92.7	80.4	97.8
Operating expenses	153	161	181
Operating income	87.2	55.5	-86.4	25.1	40.5	19.9	7.5	48.6	23.2	65.9
Interest expense	1.4	0.84	1	1.4	0.7	1.1	2.5	8.9	10.7	18.5
Interest income	0.81	1.3	0.95	1.2	0.8	0.5	1	2.1	2	3.3
Other non-operating income	0.53	1.22	0.5	0.3	3.9	-5.5	-1.6	1	-0.6	2.4
Pre-tax income	87.1	57.2	-85.9	25.2	44.5	13.8	4.4	42.8	13.9	53.1
Income tax	32.1	19.6	-25.2	3	-1.5	-2.1	5	9.1	9.8	14.3
Net income to minority interests	-0.17	-0.21	-0.3	-0.1	0	0.1	-0.5	0.2	-0.2	0
Net income	55.2	37.8	-60.4	22.3	46	15.8	-0.1	33.5	4.3	38.8
EBITDA	112	81.3	-58.5	51.3	67.4	50.1	35.4	74.2	50	102
EPS, basic	2.40	1.64	-2.64	0.99	2.04	0.70	0.00	1.47	0.19	1.70
EPS, diluted	2.38	1.63	-2.64	0.98	2.01	0.69	0.00	1.47	0.19	1.68
Shares, basic (weighted)	23	23	22.9	22.5	22.6	22.7	22.8	22.7	22.8	22.9
Shares, diluted (weighted)	23.1	23.2	22.9	22.7	22.9	22.9	22.8	22.8	22.9	23.1
Dividend per share	0.40	0.40	0.42	0.44	0.44	0.45	0.49	0.52	0.52	0.52

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	82.4	62.3	25.8	48.9	159	134	66	63.2	90.8	72
Short-term investments	1.02	1.62	1.95	1.5	4.3	8.6	3.9	5.7	3	2.1
Receivables	107	115	131	120	116	142	174	153	167	219
Inventory	360	391	356	295	250	299	393	456	423	466
Other current assets	0.36	15.2	18.8	18.2	17.5	23.5	28.2	27.7	29.8	42.8
Total current assets	577	603	561	506	566	636	696	720	723	817
Property, plant and equipment	181	190	192	190	173	172	174	188	182	222
Lease right-of-use assets			0	3.9	6.6	5.8	10.8	8.5	7.8	14.9
Goodwill	40.8	45.7	32.7	33.1	38.7	38.6	45.2	46.3	25	112
Intangible assets	26.6	31	25.4	23.5	31.2	22.7	22.5	16.4	11.2	125
Long-term investments	14	14.6	14.9	16.1	13.7	12.2	15.1	13.8	18.9	21.1
Other non-current assets	2.14	2.4	1.52	6.4	11	8.4	29.5	38.2	38	45.6
Total assets	844	890	856	801	847	906	1,014	1,059	1,044	1,367
Accounts payable	57.3	60.4	70.6	57.2	52.7	82.2	107	117	79.2	93.5
Accrued liabilities	25.7	23.3	24.1	24.7	20.8	30.6	35.3	44.1	38.2	51.2
Deferred revenue		49.4	48.1	42.9	34.2	60.2	69.5	70.2	77.3	83.7
Short-term debt	2.54	2.47	0.41	0.2	0.2	0.1	0.2	0.1	0	16.2
Total current liabilities	169	179	189	173	170	223	274	299	272	328
Long-term debt	4.12	1.58	59.7	0.7	0.4	0.2	78.1	72	105	320
Lease liabilities				2	4.7	4.2	8.3	6.5	5.5	9.7
Other non-current liabilities	20.1	20.6	20.2	23.7	34	29.6	33.3	33.5	26.9	31.3
Total liabilities	195	203	270	198	205	255	388	406	406	686
Total debt	6.65	4.04	60.1	0.9	0.6	0.3	78.3	72.1	105	336
Paid-in capital	140	142	121	123	128	131	136	138	143	150
Retained earnings	537	565	495	508	545	549	528	549	542	568
Other comprehensive income	-31.6	-24.2	-33.9	-31.8	-33.5	-32.4	-40.1	-38.1	-51.1	-40.6
Shareholders' equity	648	686	585	602	643	651	627	653	638	682
Minority interests	1.01	1.09	0.71	0.5	0.5	0.5	0	0.3	-0.2	-0.1
Total equity	649	687	585	602	642	651	627	654	638	682
Total liabilities and equity	844	890	855	801	848	906	1,014	1,059	1,044	1,367
Shares outstanding	23	23.1	22.5	22.6	22.6	22.8	22.6	22.7	22.8	22.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	55	37.6	-60.7	22.2	46	15.9	-0.6	33.7	4.1	38.8
Depreciation and amortization	24.8	25.8	27.9	26.2	26.9	30.2	27.9	25.6	26.8	36.3
Stock-based compensation	2.94	3.14	2.2	2.6	5.1	6	6.8	4.1	5	7.1
Deferred income tax	-3.52	-0.29	-25.4	1.7	8.6	-1.3	-17.1	-6.4	-7	0.4
Change in receivables	-4.9	-7.75	-16.2	7.5	12.2	-28.4	-28	20.5	-20.6	-28.4
Change in inventory	30.8	-19.6	30.8	61.3	45.9	-51.5	-96.4	-63	27.4	11.8
Cash from operations	135	41.9	-30	113	142	7.4	-73.9	27.8	23	61.4
Capital expenditures	-27.4	-20	-27.4	-23.4	-15.4	-20.1	-40.7	-34.1	-20.5	-40.7
Acquisitions	-39.8	-26.4	0	0	-32.5	0.1	-17.8	0	0	-249
Purchases of investments				-0.6	-1.1	-1	-1	-1	-1.1	-0.9
Sales and maturities of investments				1.9	1.3	1.8	0.6	1.9	0.9	1
Cash from investing	-66.2	-46.9	-27.4	-21.6	-20.9	-18.4	-53.2	-12.9	-18	-288
Debt issued							223	241	216	459
Debt repaid	-5.9	-7.24	-92	-224	-5.9	-6.2	-139	-246	-179	-230
Stock issued	0	0
Share buybacks	0	0	-24.1	0	0	0	-10.1	0	0
Dividends paid	-9.22	-9.23	-9.6	-10	-10	-10.2	-11.2	-11.8	-11.9	-11.9
Cash from financing	-11	-16.8	22.8	-68.1	-10.4	-12.1	60.1	-18.3	24.4	206
Exchange rate effect	-0.25	1.72	-1.9	0.2	-0.5	-1.1	-1.4	0.6	-1.8	1.5
Net change in cash	57.3	-20.1	-36.5	23.1	110	-24.2	-68.4	-2.8	27.6	-18.8
Free cash flow	107	21.8	-57.4	89.2	126	-12.7	-115	-6.3	2.5	20.7
Interest paid	1.41	0.59	0.9	1.8	0.3	0.3	1.1	7	8.5	16.1
Income taxes paid	28.5	26.9	8.5	-11.3	-20.2	10	17.7	13.8	8.2	19.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $41.28 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	25.7%	Gross profit / revenue.
Operating margin	3.4%	Operating income / revenue.
EBITDA margin	6.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.8%	Pre-tax income / revenue.
Net margin	1.3%	Net income / revenue.
FCF margin	2.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.2%	Cash from operations / revenue.
Effective tax rate	31.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	2.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.4%	Net income / average total assets.
Return on invested capital (ROIC)	3.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	14.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	184.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	106.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	10.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	104.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	42.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	8.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	802.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-3.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	784.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-3.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	167.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-15.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	728.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-30.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	6.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	31.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	10.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.52x	Current assets / current liabilities.
Quick ratio	0.92x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.24x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.55x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	27.0%	Total debt / total assets.
Liabilities / assets	51.3%	Total liabilities / total assets.
Net debt	$303.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.86x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	1.85x	Operating income / interest expense.
Working capital	$492.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$417.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.10x	Revenue / average total assets.
Fixed asset turnover	6.48x	Revenue / average property, plant and equipment.
Inventory turnover	2.51x	Cost of revenue / average inventory.
Days inventory	145 days	365 x average inventory / cost of revenue.
Receivables turnover	7.10x	Revenue / average receivables.
Days sales outstanding	51 days	365 x average receivables / revenue.
Days payables	34 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	163 days	Days inventory + days sales outstanding - days payables.
FCF conversion	165.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	59.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$66.77	Revenue / diluted weighted shares.
FCF per share	$1.39	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.47	Cash from operations / diluted weighted shares.
Book value per share	$29.97	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18.15	Tangible book value / shares outstanding.
Cash per share	$3.42	(Cash + short-term investments) / shares outstanding.
Payout ratio	61.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	37.0%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$950.5M	Share price x shares outstanding.
Enterprise value	$1.25B	Market cap + total debt - cash - short-term investments.
P/E	48.5x	Market cap / net income. Only when net income is positive.
P/S	0.61x	Market cap / revenue.
P/B	1.38x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.28x	Market cap / tangible book value, when positive.
P/FCF	29.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.8x	Market cap / cash from operations, when positive.
EV/Sales	0.81x	Enterprise value / revenue.
EV/EBIT	23.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	38.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.4%	Free cash flow / market cap.
Earnings yield	2.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.3%	Dividends paid over the period / market cap.
Shareholder yield	1.3%	(Dividends paid + share buybacks) / market cap.

What was ASTEC INDUSTRIES INC's revenue in fiscal 2025?

ASTEC INDUSTRIES INC reported revenue of $1.41B for fiscal 2025, 8.1% higher than the year before.

Was ASTEC INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $38.8M, a net margin of 2.8%.

How much free cash flow did ASTEC INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $61.4M minus capital expenditures of $40.7M left free cash flow of $20.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ASTEC INDUSTRIES INC